Ramiah Investment Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
+2,085
New +$399K 0.34% 43
2025
Q2
Sell
-3,073
Closed -$421K 62
2025
Q1
$421K Buy
3,073
+579
+23% +$82.8K 0.4% 40
2024
Q4
$381K Buy
2,494
+240
+11% +$40.5K 0.35% 52
2024
Q3
$437K Sell
2,254
-1,282
-36% -$268K 0.41% 50
2024
Q2
$820K Buy
+3,536
New +$768K 0.8% 23

Other funds holding BIIB

Ramiah Investment Group's BIIB Position: Q2 2026 in Review

Ramiah Investment Group opened a new position in Biogen (BIIB) in Q2 2026: 2,085 shares worth $450K. The stake represents 0.34% of the portfolio and ranks #43 among its holdings. This is a return to the name: Ramiah Investment Group previously reported a position in BIIB as recently as Q1 2025.

Ramiah Investment Group first reported a position in BIIB in Q2 2024 and has held it in 5 quarters since. The position peaked at $820K in Q2 2024. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Ramiah Investment Group held 2,085 shares of Biogen worth $450K as of Q2 2026.
  • Biogen was a new Ramiah Investment Group position in Q2 2026.
  • Biogen made up 0.34% of Ramiah Investment Group's portfolio in Q2 2026, its #43 holding.
  • Ramiah Investment Group first reported a position in Biogen in Q2 2024 and has held it in 5 quarters since.
  • Ramiah Investment Group's Biogen position peaked at $820K in Q2 2024.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.